¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Expert opinion on emerging drugs."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® parenteral administration of drugs ÇÑ±Û ºñ°æ±¸Àû ¾àǰÅõ¿©
¼³¸í   
  ÀÔÀ» ÅëÇÏÁö ¾Ê´Â ´Ù¾çÇÑ ¾àǰÅõ¿© ¹æ¹ýÀ» ¸»ÇÔ. ÁÖ»ç±â¸¦ ÀÌ¿ëÇÑ´Ù.
  
  1)ÇÇÇÏÁÖ»ç: subcutaneous injection-ÇǺΠ¹ØÀ¸·Î ÁÖ»çÇϴ °Í. ´ë°³ ÆÈÀÇ Áß°£ºÎ¿¡ ÁÖ»çÇÑ´Ù.
  
  2)ÁøÇdz»ÁÖ»ç: intradermal injection-¾ã°Ô Âñ·¯¼­ ÁøÇdz»¿¡ ÁÖ»çÇÑ´Ù. ÁַΠ¾Ë·¯Áö È¯ÀÚÀÇ Ç׿ø°Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù.
  
  3)±ÙÀ°³»ÁÖ»ç: intramuscular injection-À§ÆÈÀ̳ª, È¤Àº ¾ûµ¢ÀÌ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. À̰ÍÀº ÁַΠÇǺο¡ ÀÚ±ØÀÌ ½ÉÇÑ ¾àÁ¦³ª È¤Àº ÃµÃµÈ÷ ÀÛ¿ëÇϴ ¾àÁ¦¸¦ ¸¹ÀÌ ÁÖ»çÇÒ ¶§ »ç¿ëÇÑ´Ù.
  
  4)Ç÷°üÁÖ»ç: intravenous(IV) injection-Á¤¸ÆÀ» ÅëÇØ ÁÖ»çÇÑ´Ù. ¾î´À Á¤¸ÆÀ̳ª °¡´ÉÇÏÁö¸¸, ´ë°³ ÆÈ¶ÒÀ̳ª ¹ß µîÀÇ Á¤¸ÆÀ» ÀÌ¿ëÇÑ´Ù. ºü¸¥ Ä¡·áÈ¿°ú¸¦ º¸±â À§ÇØ »ç¿ëÇÑ´Ù. À̶§ ÇǺο¡ ÀÚ±ØÀ» Áִ ¾àÁ¦À̸é, »õÁö ¾Êµµ·Ï Á¶½ÉÇØ¾ß ÇÑ´Ù.
  
  5) ¼ö¸·°­³»ÁÖ»ç: intrathecal injection-µÎ°³³ª Ã´¼ö°­³»¿¡ ÁÖ»çÇÒ ¶§ ÀÌ¿ëÇÑ´Ù.
  
  6)°­³»ÁÖ»ç: intracavitary injection-°ø°£À¸·Î µÈ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. ¿¹¸¦ µé¾î º¹ºÎ°ø°£À̳ª Èä°­³»¿¡ ÁÖ»çÇÏ¿© »ç¿ëÇÑ´Ù.
¿µ¹® rectal administration of drugs ÇÑ±Û ¾à¹°ÀÇ °ðâÀÚÁ¾à½Ä Åõ¿©
¼³¸í   
  ÀÔÀ» ÅëÇØ ¸ÔÀº ¾à¹°Àº Èí¼öµÈ ÈÄ °£À» °ÅÃÄ º´º¯ºÎÀ§·Î ¿î¹ÝµÈ´Ù. µû¶ó¼­ °£¿¡¼­ ´ë»ç°¡ µÇ¾î ¾à¹°·Î¼­ÀÇ È¿°ú°¡ ¾ø¾îÁú °¡´É¼ºÀÌ ÀÖÀ» »Ó ¾Æ´Ï¶ó °£¿¡ µ¶¼ºÀÛ¿ëÀ» ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. ÀÌ·¯ÇÑ ´ÜÁ¡À» º¸¿ÏÇϱâÀ§ÇØ °£À» ÅëÇÏÁö ¾Ê°í À绡¸® Èí¼öµÇ¾î º´º¯À¸·Î °¥ ¼ö Àִ ¹æÆíÀ¸·Î Á÷ÀåÁ¾àÀ» »ç¿ëÇÑ´Ù. Á÷ÀåÀÇ Á¤¸ÆÈ帧Àº °£À» °ÅÄ¡Áö ¾Ê°í Á÷Á¢ ÇÏ´ëÁ¤¸ÆÀ» ÅëÇØ ¿ì½É¹æÀ¸·Î Èê·¯µé±â ¶§¹®ÀÌ´Ù. 
¿µ¹® side effects of drugs ÇÑ±Û ¾à¹°ÀÇ ºÎÀÛ¿ë
¼³¸í   
  ¾àÀ» »ç¿ëÇÒ ¶§ ±â´ëÇϴ ȿ°ú ¿Ü¿¡ ´Ù¸¥ Àå±â¿¡¼­ ³ªÅ¸³ª´Â ¿øÄ¡ ¾Ê´Â È¿°ú¸¦ ÃÑĪÇϴ ¸»ÀÌ´Ù. ¿¹¸¦ µé¾î Ç÷¾ÐÀ» ³·Ãß±â À§ÇØ Ç×°íÇ÷¾ÐÁ¦¸¦ »ç¿ë ½Ã, Ç÷¾ÐÀÌ ¶³¾îÁö´Â µ¿½Ã¿¡ ±â°üÁöÀÇ ¼öÃàÀÌ ÀϾ´Â Çö»ó.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • natural emerging method
    ÀÚ¿¬À¯Ãâ¹ý
  • second opinion
    ÀÌÂ÷Àǰß
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • natural emerging method
    ÀÚ¿¬À¯Ãâ¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anemia expert system
    ºóÇ÷Àü¹®°¡½Ã½ºÅÛ
  • Ganglionic blocking drugs
    ½Å°æÀýÂ÷´Ü¾àÁ¦(ãêÌèï½ó´Ó¨å·ð¥)
  • antimalarial drugs
    Ç׸»¶ó¸®¾ÆÁ¦(ù÷¡­ð¥).
  • galenical preparation =crude drugs
    »ý¾à (ßæå·).
  • hydantoinlike drugs
    È÷´ÜÅäÀξç¾àÁ¦.
  • illict drugs
    ºÒ¹ý¾à¹°
  • poisoning by drugs
    ¾à¹°Áßµ¶(ËâËÑÌ¡ËÄ).
  • poisoning by drugs
    ¾à¹°Áßµ¶(å·ÚªñéÔ¸).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • second opinion
    Á¦2ÀÇ°ß Á¦½Ã ÇÁ·Î±×·¥.
  • anemia expert system
    ºóÇ÷Àü¹®°¡½Ã½ºÅÛ
  • expert evidence
    Àü¹®Áõ¾ð(¡­ñûåë).
  • expert system
    Àü¹®°¡Ã¼°è, Àü¹®°¡½Ã½ºÅÛ
  • expert witness
    °¨Á¤ÀÎ(ÊüïÒìÑ)
  • antimalarial drugs
    Ç׸»¶ó¸®¾ÆÁ¦(ù÷¡­ð¥).
  • drugs
    ¾à¹°(å·Úª)
  • drugs,interaction
    »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • drugs,overdosage
    °ú·®(ΦÕá)
  • drugs,side effects
    ºÎÀÛ¿ë(ÜùíÂéÄ)
  • drugs,therapeutic
    Ä¡·á(Àû)(ö½ÖûîÜ)
  • galenical preparation =crude drugs
    »ý¾à (ßæå·).
  • hydantoinlike drugs
    È÷´ÜÅäÀξç¾àÁ¦.
  • illict drugs
    ºÒ¹ý¾à¹°
  • official drugs ³ª officinalis remedies
    ¾àÀü¾à(å·îðå·), °øÁ¤¾à(ÍëïÒå·).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • natural emerging method
    ÀÚ¿¬À¯Ãâ¹ý
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • JPEG [=joint photographic expert group]
    JPEG
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DxPLAIN Massachusetts General Hospital's expert diagnostic system
MedIndEx medical indexing expert
MEDSTATS Medical Statistics Expert System
QFES Quality Feedback Expert System
imho in my humble(or honest) opinion
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ATD Antithyroid drugs
DMARD Disease Modifying Antirheumatic Drugs
ECBS Expert Committee on Biological Standardisation
ES Expert System
JECFA Joint FAO-WHO Expert Committee on Food Additives
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 31718
    JournalTitle: Expert opinion on emerging drugs.
    MedAbbr: Expert Opin Emerg Drugs
    ISSN: 1472-8214
    ESSN:
    IsoAbbr:
    NlmId: 101135662
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • expert witness
    °¨Á¤ÀÎ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
public opinion The attitude of a significant portion of a population toward any given proposition, based upon a measurable amount of factual evidence, and involving some degree of reflection, analysis, and reasoning.
(12 Dec 1998)
emerging viruses In epidemiology, a class of viruses that have long infected humans or animals but now have the opportunity to attain epidemic proportions due to human encroachment on tropical rainforests, increased international travel, burgeoning populations in less developed countries, and, possibly, global warming. About two dozen viruses have been termed emergent, including haemorrhagic viruses such as Ebola, Marburg, and Hantaan; the rabies-like viruses Mokola and Duvenhage; rodent-borne Jinin and Lassa virus; and mosquito-borne dengue. Virologists speculate that the strain of HIV that causes AIDS may also fall into this category, having entered humans through contact with monkeys in central Africa, possibly having existed among monkey populations for some 50,000 years.
(05 Mar 2000)
expert system Expert systems are computer programs designed to simulate the problem-solving behaviour of human experts within very narrow domains or scientific disciplines (entomology, plant pathology, etc.).
This discipline is a sub-set of Artificial Intelligence.
See: artificial intelligence.
Synonym: knowledge-based systems
(13 Jan 1998)
expert systems Computer programs based on knowledge developed from consultation with experts on a problem, and the processing and/or formalizing of this knowledge using these programs in such a manner that the problems may be solved.
(12 Dec 1998)
expert testimony Presentation of pertinent medical data by a qualified medical specialist before a court.
(12 Dec 1998)
veterinary drugs Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the united states most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products.
(12 Dec 1998)
cytotoxic drugs <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells.
See: chemotherapy.
(13 Nov 1997)
psychotropic drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquillising agents (including the antipsychotics and anti-anxiety agents).
(12 Dec 1998)
neuroleptic drugs Literally nerve seising: used of chlorpromazine like drugs. Antagonise the effects of dopamine.
Origin: Gr. Lepsis = a taking hold
(18 Nov 1997)
street drugs Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.
(12 Dec 1998)
designer drugs Drugs designed and synthesised, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are mptp (a reverse ester of meperidine), mda (3,4-methylenedioxyamphetamine), and mdma (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
(12 Dec 1998)
drugs, chinese herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesised compounds manufactured in china.
(12 Dec 1998)
drugs, essential Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3)
(12 Dec 1998)
drugs, generic Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
(12 Dec 1998)
drugs, investigational Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (treatment ind). The main heading includes drugs under investigation in foreign countries.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • emerging
    ÃÖ±Ù »ý°Ü³­;ÃÖ±Ù¿¡ ¸¸µé¾îÁø
  • expert
    Àü¹®°¡
  • expert
    ¼÷·ÃÀÚ;³ë·Ã°¡;Àü¹®°¡;±â»ç;°¨Á¤ÀÎ;¼÷´ÞµÈ;³ë·ÃÇÑ
  • opinion
    Àǰß,°ßÇØ,(º¹¼ö)¼Ò½Å
  • curbstone opinion
    ½ÃÁ¤ÀÇ Àǰß
  • dissenting opinion
    (¹ý)¹Ý´ëÀÇ
  • general opinion
    ÀϹÝÀû °ßÇØ;(ÀϹÝÀû)¿©·Ð
  • opinion
    ~ of ...À» ÁÁ°Ô(³ª»Ú°Ô)»ý°¢ÇÏ´Ù;have the courage of one's ~s ¼Ò½ÅÀ» ´ç´çÇÏ°Ô Ç¥¸íÇÏ´Ù
  • opinion poll
    ¿©·ÐÁ¶»ç
  • public opinion
    ¿©·Ð
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á